share_log

HC Wainwright & Co. Maintains Buy on AnaptysBio, Lowers Price Target to $52

HC Wainwright & Co. Maintains Buy on AnaptysBio, Lowers Price Target to $52

HC Wainwright公司繼續買入anaptysbio股票,將目標價調低至$52
Benzinga ·  2024/11/07 02:45  · 評級/大行評級

HC Wainwright & Co. analyst Emily Bodnar maintains AnaptysBio (NASDAQ:ANAB) with a Buy and lowers the price target from $55 to $52.

HC Wainwright分析師Emily Bodnar維持anaptysbio(納斯達克:ANAB)買入評級,將目標股價從55美元降至52美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論